Fact Sheet
Flexible Design for Novel Trials
Cenduit IRT supports national lung cancer trial
Nov 10, 2020
Download
Cenduit currently provides randomization and trial supply management for the world’s largest precision medicine trial to investigate treatment for non-small cell lung cancer. This trial is investigating genetic biomarker targeted therapy combinations, via partnership between non-profit research organizations and large pharmaceutical companies.

Related solutions

Contact Us